Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Maitra, Anirban New York University School Of Medicine United States Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D. Maitra, Anirban New York University School Of Medicine United States Clinical Validation Center for Early Detection of Pancreatic Cancer 7U01CA200468-09 Matthew Young, Ph.D. Majumder, Shounak Mayo Clinic Rochester United States Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-09 Matthew Young, Ph.D. Markowitz, Sanford D. Case Western Reserve University United States Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation 5U01CA271867-04 Matthew Young, Ph.D. Markowitz, Sanford D. Case Western Reserve University United States Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation 5U01CA271867-04 Matthew Young, Ph.D. Martinez-Conde, Susana Suny Downstate Medical Center United States Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance 5R01CA258021-05 Guillermo Marquez, Ph.D. Mehta, Anand S. Medical University Of South Carolina United States Glycan Biomarkers for Cholangiocarcinoma 5R01CA289381-02 Sidney Fu, M.D. Mello-Thoms, Claudia R University Of Iowa United States Satisfaction of Search in Breast Cancer Detection 5R01CA259048-05 Metzger, Gregory John University Of Minnesota United States Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI 4R01CA241159-05 Guillermo Marquez, Ph.D. Miyano, Masaru Beckman Research Institute/City Of Hope United States Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials 1R03CA300614-01 Sidney Fu, M.D. Mu, Ping Yale University United States Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation 5R01CA292949-03 Indu Kohaar, Ph.D., M.Phil., M.Sc. Nabavi, Sheida University Of Connecticut Storrs United States SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening 5R01CA297855-02 Claire Zhu, Ph.D. Neslund-Dudas, Christine Marie Henry Ford Health + Michigan State University Health Sciences United States HFH-MSU CSRN ACCrual Enrollment and Screening Site 5UG1CA287007-03 Elyse LeeVan, M.D., M.P.H. Oberg, Ann Laura Mayo Clinic Rochester United States Management and Data Coordination Unit for PCDC 5U24CA274496-04 Guillermo Marquez, Ph.D. Oskeritzian, Carole A University Of South Carolina At Columbia United States Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity 5R21CA274021-02 Guillermo Marquez, Ph.D. Pagination « First First page ‹ Previous Previous page … 8 9 10 11 … Next › Next page Last » Last page
